BofA Merrill Lynch J.P. · PDF file 2018-05-03 · Use these links to rapidly review...

Click here to load reader

  • date post

    03-Aug-2020
  • Category

    Documents

  • view

    1
  • download

    0

Embed Size (px)

Transcript of BofA Merrill Lynch J.P. · PDF file 2018-05-03 · Use these links to rapidly review...

  • Use these links to rapidly review the document

    TABLE OF CONTENTS Prospectus Supplement

    TABLE OF CONTENTS

    Table of Contents

    Filed Pursuant to Rule 424(b)(5) Registration Statement No. 333-208058

    The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not offers to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

    Subject To Completion, Dated May 3, 2018

    Preliminary Prospectus Supplement to Prospectus dated November 16, 2015

    $                

    Oshkosh Corporation % Senior Notes due

            We are offering $            aggregate principal amount of our        % Senior Notes due                (the "notes"). The notes will bear interest at a rate of        % per year, payable semi-annually in arrears on                and                of each year, beginning on                , 2018. The notes will mature on                 ,                . We may redeem the notes in whole at any time or in part from time to time at the applicable redemption price described under "Description of the Notes—Optional Redemption." The notes will be issued only in registered form in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

            The notes will be our senior unsecured obligations and will rank equally in right of payment with our existing and future senior unsecured indebtedness.

             You should carefully consider the discussion under "Risk Factors" beginning on page S-7 of this prospectus supplement and in the reports we file with the U.S. Securities and Exchange Commission (the "SEC") that are incorporated by reference into this prospectus supplement and the accompanying prospectus.

             Neither the SEC nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus supplement and the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

             

    Per Note Total  

    Public offering price (1)                       %   $                      

    Underwriting discount                       %   $                      

    Proceeds, before expenses, to us                       %   $                      

    (1) Plus accrued interest, if any, from                , 2018, if settlement occurs after that date.

            The underwriters expect to deliver the notes to purchasers through the book-entry delivery system of The Depository Trust Company ("DTC") for the accounts of its participants, including Clearstream Banking, S.A. ("Clearstream"), and Euroclear Bank SA/NV ("Euroclear"), on or about                        , 2018, against payment therefor in immediately available funds.

  • Joint Book-Running Managers

    US Bancorp    

    Prospectus Supplement dated                , 2018

    BofA Merrill Lynch   J.P. Morgan   Wells Fargo Securities

  • Table of Contents

             No person has been authorized by us to provide any information or to make any representations other than those contained in or incorporated by reference in this prospectus supplement, the accompanying prospectus or any related free writing prospectus that we deliver to you and, if given or made, such information or representations must not be relied upon as having been authorized. You should carefully evaluate the information provided by us in light of the total mix of information available to you, recognizing that we can provide no assurance as to the reliability of any information not contained in or incorporated by reference in this prospectus supplement, the accompanying prospectus or any related free writing prospectus that we deliver to you. We are not, and the underwriters are not, making an offer to sell the notes in any jurisdiction where the offer or sale is not permitted. Unless otherwise indicated, you should assume that the information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus is accurate as of the date on the front of this prospectus supplement only. Our business, financial condition, results of operations and prospects may have changed since that date.

    TABLE OF CONTENTS

    Prospectus Supplement

    Prospectus

    ABOUT THIS PROSPECTUS SUPPLEMENT   i NON-GAAP FINANCIAL MEASURES   ii CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS   ii PROSPECTUS SUPPLEMENT SUMMARY   S-1 RISK FACTORS   S-7 RATIO OF EARNINGS TO FIXED CHARGES   S-10 USE OF PROCEEDS   S-10 CAPITALIZATION   S-11 DESCRIPTION OF THE NOTES   S-12 CERTAIN U.S. FEDERAL INCOME TAX CONSEQUENCES   S-28 UNDERWRITING (CONFLICTS OF INTEREST)   S-33 WHERE YOU CAN FIND MORE INFORMATION   S-40 LEGAL MATTERS   S-40 EXPERTS   S-40

    ABOUT THIS PROSPECTUS   1 CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS   1 OSHKOSH CORPORATION   2 RATIO OF EARNINGS TO FIXED CHARGES   2 USE OF PROCEEDS   2 DESCRIPTION OF CAPITAL STOCK   2 DESCRIPTION OF DEPOSITARY SHARES   4 DESCRIPTION OF DEBT SECURITIES   5 DESCRIPTION OF WARRANTS   17 DESCRIPTION OF STOCK PURCHASE CONTRACTS AND STOCK PURCHASE UNITS   18 SELLING SHAREHOLDERS   19 PLAN OF DISTRIBUTION   19 WHERE YOU CAN FIND MORE INFORMATION   21 LEGAL MATTERS   22 EXPERTS   23

  • Table of Contents

    ABOUT THIS PROSPECTUS SUPPLEMENT

            This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering. The second part, the accompanying prospectus, gives more general information, some of which may not apply to this offering.

            If information in this prospectus supplement is inconsistent with the accompanying prospectus, you should rely on this prospectus supplement. This prospectus supplement, the accompanying prospectus, any free writing prospectus we have authorized and the documents incorporated into each by reference include important information about us, the notes being offered and other information you should know before investing. You should read this prospectus supplement and the accompanying prospectus as well as additional information described under "Where You Can Find More Information" in this prospectus supplement and the accompanying prospectus before investing in the notes.

            You should rely only on the information contained or incorporated by reference in this prospectus supplement, the accompanying prospectus and any free writing prospectus we have authorized. We have not, and the underwriters have not, authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. You should assume that the information contained or incorporated by reference in this prospectus supplement, the accompanying prospectus or any free writing prospectus we have authorized is accurate only as of the date of such document or the documents containing such incorporated information, regardless of the time of delivery of this prospectus supplement and the accompanying prospectus or any sales the notes. Our business, financial condition, results of operations and prospects may have changed since those dates.

            Unless the context otherwise requires, the terms "Company", "we", "our" and "us" and other similar terms mean Oshkosh Corporation and its consolidated subsidiaries. References in this prospectus supplement to a "fiscal year" are to our fiscal year ended September 30.

    i

  • Table of Contents

    NON-GAAP FINANCIAL MEASURES

            EBITDA as presented in this prospectus supplement is a supplemental measure of our performance that is not required by, or presented in accordance with, accounting principles generally accepted in the United States ("GAAP"). This measure is not a measurement of our financial performance or liquidity under GAAP and should not be considered as an alternative to net income, operating income from continuing operations or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as measures of our liquidity.

            We define "EBITDA" as earnings before interest expense, interest income, provision for income taxes, depreciation and amortization. See "Prospectus Supplement Summary—Summary Financial Information." We caution investors that amounts presented in accord